compound introduction
Taragarestrant (D-0502) meglumine is a potent, orally active and selective estrogen receptor degrader (SERD). Taragarestrant meglumine shows potent activity in various ER+ breast cancer cell lines and xenograft models. In Vivo Taragarestrant (D-0502) exhibits superior PK profiles suitable for clinical development . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid
